Cancer Research UK has awarded a 20-million-pound grant (about $26 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.
News: January, 2019
Lucy Spalluto, MD, and Jennifer Lewis, MD, MS, are co-leading the Veterans Affairs-Partnership to increase Access to Lung Screening (VA-PALS) National Program Evaluation, which aims to implement lung screening programs and improve access to early detection of lung cancer for at-risk veterans.
As many as 50 percent of stem cell transplant recipients develop diabetes. Brian Engelhardt, M.D., and an interdisciplinary team of experts in diabetes, immunology, endocrine surgery and transplantation are determined to understand why.
Carlos F. Lopez, PhD, and colleagues propose a new “conveyor belt” mechanism for how cellular signaling is amplified, or strengthened, as signals are handed off from one enzyme to the next.
A recent study shows that a component of the DNA primase enzyme acts as a reversible on/off switch for DNA binding and represents a fundamentally new method of communication between DNA-processing enzymes.
Immunotherapies that take off the “brakes” on the adaptive anti-tumor response have worked well in melanoma and lung cancer but less so in breast cancers. That could change.
GE Healthcare, Vanderbilt University Medical Center partner for safer, more precise immunotherapy cancer treatmentWednesday, January 16th, 2019
GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enable safer and more precise cancer immunotherapies.
Jeremy Warner, MD, MS, associate professor of Medicine and Biomedical Informatics, has been awarded a $1 million grant from the National Cancer Institute to develop software that will help clinicians keep up with the increasing complexity of cancer care.
A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.